Study Title: A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Kraveka, Jacqueline, at kravekjm@musc.edu.Study Coordinator, Pound, Ashton, at pound@musc.edu, or please call +1 843-792-6078.Trial opened at the following institutions: Medical University of South Carolina